<i>In silico</i>and<i>in vitro</i>evaluation of exonic and intronic off-target effects form a critical element of therapeutic ASO gapmer optimizationPiotr J. Kamola, Joel D. Parry, Kitty Moores et al.|Nucleic Acids Research|2015Cited by 109
Strategies for In Vivo Screening and Mitigation of Hepatotoxicity Associated with Antisense DrugsPiotr J. Kamola, Joel D. Parry, Klio Maratou et al.|Molecular Therapy — Nucleic Acids|2017Cited by 62
Single-Step, High-Efficiency CRISPR-Cas9 Genome Editing in Primary Human Disease-Derived FibroblastsMatteo Martufi, Klio Maratou|The CRISPR Journal|2019Cited by 26
Single step, high efficiency CRISPR-Cas9 genome editing in primary human disease-derived fibroblastsMatteo Martufi, Klio Maratou|bioRxiv (Cold Spring Harbor Laboratory)|2018Cited by 3